Europe's health & life sciences magazine launching on 12 October 2026. Four issues a year, in print. For innovators, health systems, policymakers, healthcare professionals, investors, patient organisations, and more.
Issue 01 - Counting on Europe - Autumn 2026 now available!
Reporting on health and life sciences in Europe for Rapporteur (Euractiv), EU Perspectives, European Biotechnology Magazine and APM Market Access.
Commissioned writing and editing for organisations in health and life sciences. Interviews, features, reports, and the editing that makes them shine.
EU PERSPECTIVES - A European company is developing a device that could help doctors better manage heart failure. Yet, US patients will get it first. Its CEO says in an interview that the EU's reimbursement system is to blame. Read more
EU PERSPECTIVES - Investors want evidence before they back new tests, but without investment, the data needed to prove their value may never materialise. Berlin startup theblood hopes menstrual blood could help close that gap in conditions such as endometriosis, although EU rules for diagnostic tests do not yet explicitly recognise the sample. Read...
NEXXAHEALTH - For years, Europe's low medicine prices and its patchwork of national markets were things it could live with. America's new pricing rules has turned both against it. Bas Amesz, who a decade ago proposed a different way to pay for medicines, argues the shock is Europe's chance to buy innovation as a single bloc, and...
RAPPORTEUR (EURACTIV) - Four in five countries now have a national cancer plan, but three in four governments have not costed theirs. From Mexico to Romania, the gap between strategy and results looks the same. Read more
